Yahoo: Researchers find a new treatment for rare muscular disease
UC research presented at national meeting reveals a new possible treatment for Pompe disease
University of Cincinnati researchers have found a newer, more effective treatment for Pompe disease that could become the new standard of care for the rare condition.
Rare diseases are sometimes the most difficult to treat because of a lack of research and fewer participants to study. An example would be those who have Pompe disease, a genetic condition when a body can't make a protein that breaks down a complex sugar, called glycogen, for energy. Too much glycogen builds up and damages muscles and organs. The disease causes muscle weakness and trouble breathing and can affect the heart and muscles.
Hani Kushlaf, MD, an associate professor in both the Department of Neurology and Rehabilitation Medicine and the Department of Pathology and Laboratory Medicine at UC and principal investigator of a study led at UC, will present findings on this new treatment virtually at the American Academy of Neurology on April 20. Kushlaf is also a UC Health physician and a member of the UC Gardner Neuroscience Institute.
Featured photo of Hani Kushlaf, MD, provided by UC Health.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up to date on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Sports Illustrated: Bearcats football embodies UC work ethic
December 1, 2021
Sports Illustrated featured the rise of the University of Cincinnati Bearcats football team, which is undefeated in regular season play for the second consecutive year and ranked No. 4 by the College Football Playoff selection committee. The article touts the connection between the tireless work ethic of the team and the university’s 115-year-old cooperative education (co-op) program.
New sites available now on Bearcats Landing
December 1, 2021
New sites available now on Bearcats Landing as fall semester site builds are completed.
UC research shows effectiveness of ointment that kills...
December 1, 2021
Research from the University of Cincinnati College of Medicine shows that use of a topical drug, called AB569, a combination of acidified nitrite and EDTA (or ethylenediaminetetraacetic acid) promotes killing of antibiotic-resistant bacteria while enhancing the healing of wounds in a variety of burn injuries. The study was published in the journal Infection and Immunity.